IgE-mediated hypersensitivity: patients with complex regional pain syndrome type 1 (CRPS1) vs the Dutch population. A retrospective study

Pain Medicine : the Official Journal of the American Academy of Pain Medicine
Feikje WesseldijkFreek J Zijlstra

Abstract

To investigate whether hypersensitivity is more common in Complex Regional Pain Syndrome type 1 (CRPS1) patients than in the general population. In a recent study, the level of tryptase, a specific marker for mast cells, was significantly higher in blister fluid from the involved extremity of CRPS1 patients. This suggested that mast cells may play a role in the pathophysiology of CRPS1. Mast cells are major effectors in allergic reactions, and are also involved in a variety of noninfectious inflammatory diseases. Patients. Sixty-six Dutch patients with CRPS1 in one extremity were included. Allergy information was obtained from the medical history and a modified questionnaire based on the Europees Luchtweg Onderzoek Nederland 1 study. Total IgE and allergen-specific IgE were measured from blood samples. Also tryptase, as a marker for mast cells, was measured. The data from the questionnaire were compared with that of the general Dutch population, and the plasma levels were compared with reference values and data in the literature. The medical history did not differ from information provided in the questionnaire by the CRPS1 group. There was no significant difference between the answers to the questionnaire between the CRPS1 pati...Continue Reading

References

Jul 1, 1991·The British Journal of Dermatology·B DeleuranK Thestrup-Pedersen
Aug 1, 1981·The Journal of Allergy and Clinical Immunology·R A BarbeeB Burrows
Oct 1, 1980·The Journal of Allergy and Clinical Immunology·H J WittigG Royal
Feb 1, 1994·The Journal of Allergy and Clinical Immunology·J J JansenT Ockhuizen
Feb 1, 1994·Journal of Dermatological Science·U AmonH H Wolff
Sep 1, 1997·Methods : a Companion to Methods in Enzymology·R G Hamilton
Nov 14, 1997·Physiological Reviews·D D MetcalfeY A Mekori
Sep 7, 2000·Archives of Pathology & Laboratory Medicine·W E WinterS Fuhrman
Nov 8, 2001·European Journal of Pharmacology·F J HuygenF J Zijlstra
Mar 14, 2002·Current Rheumatology Reports·Robert J Schwartzman, Anca Popescu
Mar 29, 2002·International Archives of Allergy and Immunology·Cem Akin, Dean D Metcalfe
Apr 5, 2002·Mediators of Inflammation·Frank J P M HuygenFreek J Zijlstra
Feb 20, 2003·The Journal of Allergy and Clinical Immunology·Robert G Hamilton, N Franklin Adkinson
Oct 24, 2003·Lancet Neurology·Wilfrid Jänig, Ralf Baron
Mar 17, 2004·Immunology Letters·Frank J P M HuygenFreek J Zijlstra
May 26, 2004·Journal of Pain and Symptom Management·Frank J P M HuygenPaul L A van Daele
Jul 9, 2004·The Journal of Allergy and Clinical Immunology·Hae-Ki MinLawrence B Schwartz
Feb 25, 2005·Journal of Neurology·Frank Birklein
Mar 1, 2005·Journal of Clinical Pathology·A S JanssensA P Oranje
May 26, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·A W van Toorenenbergen, A P Oranje
Jun 18, 2005·Brain Research. Brain Research Reviews·Theoharis C TheoharidesAphrodite Konstantinidou
Jun 21, 2005·Pain·Guillermo M AlexanderRobert J Schwartzman
Sep 15, 2005·The Journal of Allergy and Clinical Immunology·Deborah JarvisPeter Burney
Oct 22, 2005·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·M OsterballeC Bindslev-Jensen
Nov 18, 2005·European Journal of Gastroenterology & Hepatology·Anne Denise Moneret-Vautrin
Feb 21, 2006·Mediators of Inflammation·Renate J M MunnikesFrank J P M Huygen
Mar 4, 2006·The Clinical Journal of Pain·Christian SchinkelMatthias Schuermann
Jun 6, 2006·The Journal of Allergy and Clinical Immunology·Michael F Gurish, Joshua A Boyce
Jul 11, 2006·Current Opinion in Allergy and Clinical Immunology·Franziska RuëffBernhard Przybilla
Aug 29, 2006·Journal of Pharmacological Sciences·Akihiko Ito, Junko Oonuma
Nov 17, 2006·International Archives of Allergy and Immunology·Aurelia CarossoRoberto DeMarco

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

© 2022 Meta ULC. All rights reserved